Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	122,546	76,884	56,100	-	-	-
Market Cap Growth	37.05%	37.05%	-	-	-	-
Enterprise Value	118,861	73,458	56,019	-	-	-
Last Close Price	305.60	191.73	139.90	-	-	-
PE Ratio	33.04	20.74	-	-	-	-
Forward PE	1856.75	71.91	-	-	-	-
PS Ratio	21.05	13.20	99.85	-	-	-
PB Ratio	31.54	19.79	369.39	-	-	-
P/TBV Ratio	31.75	19.92	452.87	-	-	-
P/FCF Ratio	30.83	19.34	-	-	-	-
P/OCF Ratio	30.19	18.94	-	-	-	-
EV/Sales Ratio	20.41	12.62	99.70	-	-	-
EV/EBITDA Ratio	31.56	19.57	-	-	-	-
EV/EBIT Ratio	32.24	19.93	-	-	-	-
EV/FCF Ratio	29.90	18.48	-	-	-	-
Debt / Equity Ratio	0.53	0.53	4.48	0.59	0.87	0.33
Debt / EBITDA Ratio	0.55	0.55	-	-	-	5.68
Debt / FCF Ratio	0.52	0.52	-	-	-	2.38
Asset Turnover	1.36	1.36	0.33	0.48	0.80	0.95
Inventory Turnover	1.87	1.87	2.00	2.59	2.75	2.82
Quick Ratio	2.99	2.99	0.52	1.73	0.62	0.89
Current Ratio	3.19	3.19	0.74	1.94	0.90	1.07
Return on Equity (ROE)	183.64%	183.64%	-143.77%	-44.62%	-25.51%	8.62%
Return on Assets (ROA)	53.82%	53.82%	-28.74%	-14.01%	-10.00%	-1.34%
Return on Capital (ROIC)	67.89%	67.89%	-42.44%	-19.63%	-16.33%	-2.33%
Return on Capital Employed (ROCE)	71.50%	71.50%	-	-	-	-
Earnings Yield	3.03%	4.82%	-1.39%	-	-	-
FCF Yield	3.24%	5.17%	-1.24%	-	-	-
Payout Ratio	1.03%	1.03%	-	-	-	26.28%
Buyback Yield / Dilution	-0.14%	-0.14%	-10.56%	-1.38%	-3.64%	10.86%
Total Shareholder Return	-0.14%	-0.14%	-10.56%	-1.38%	-3.64%	10.86%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.